Navigation Links
Adynxx Initiates Phase 2 Dose-Ranging Study of AYX1, Lead Compound for the Prevention of Post-Surgical Pain
Date:7/16/2014

SAN FRANCISCO, July 16, 2014 /PRNewswire/ -- Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain. With ADYX-003, Adynxx will build on the results of the recently completed ADYX-002 Phase 2 proof-of-concept study.

The 120-patient, placebo-controlled study will evaluate the safety and efficacy of two dose-volume levels of a single administration of AYX1 given prior to unilateral total knee replacement to reduce acute pain with movement and to prevent the transition to persistent pain. The study will follow patients for 42 days with a primary endpoint of pain with walking. Secondary endpoints include pain at rest, pain with knee range of motion, opioid consumption and extent of functional recovery. Further details of the study can be found at www.clinicaltrials.gov.

"In the ADYX-002 proof-of-concept study, AYX1 was well-tolerated and demonstrated a consistent treatment effect across a spectrum of pre-defined movement-evoked pain and range-of-motion assessments. Further, this first efficacy study was very informative regarding the dose-volume relationship that drives the AYX1 treatment effect at its site of action," said Donald Manning, M.D., Ph.D., chief medical officer of Adynxx. "The current ADYX-003 study is designed to leverage these first Phase 2 data to further enhance the scope and magnitude of the AYX1 therapeutic effect." 

"The clinical results to date support Adynxx's approach to the treatment of pain and we are committed to advancing the development of AYX1 as rapidly as possible," added Julien Mamet, Ph.D., founder and chief scientific office
'/>"/>

SOURCE Adynxx
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
2. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
3. Lead Therapeutic Candidate for Treatment of Pain from Adynxx, AYX1, Well-Tolerated in Phase 1 Clinical Study
4. Adynxx Completes Enrollment in Phase 1 Clinical Study of Lead Therapeutic for Treatment of Pain, AYX1
5. Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation
6. MEI Pharma Initiates Phase II Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome
7. Tandem Diabetes Care Initiates Voluntary Recall for Specific Lots of Insulin Cartridges Used with t:slim Insulin Pump
8. Labrys Biologics Initiates Two Phase 2 Studies of LBR-101 for the Prevention of Chronic and Episodic Migraine
9. Scioderm Initiates Phase 2B Study of SD-101, A Novel Topical Therapy, for Patients with Epidermolysis Bullosa
10. Cameron Associates Initiates Coverage of Brainsway, Ltd.
11. Heptares Initiates Clinical Study With First Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients With Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 01, 2015 Research and Markets ... of the "US ACO IT Spending Outlook 2018" ... expected that number of lives covered by ACO would ... In this report, the ACO IT spending has been ... spending on software and spending on services. Our research ...
(Date:5/1/2015)... Calif. , May 1, 2015  Thoratec Corporation (NASDAQ: ... therapies to save, support and restore failing hearts, announced today ... newly created role of President, International. This new ... Thoratec commercial operations outside of North America ... , and Latin America , and ...
(Date:5/1/2015)... 2015  CytRx Corporation (CYTR), a biopharmaceutical research ... financial results for the three months ended March ... accomplishments and upcoming milestones for its clinical development ... the early months of 2015, including the announcement ... aldoxorubicin in patients with soft tissue sarcoma, and ...
Breaking Medicine Technology:United States ACO IT Spending Outlook 2014-2018 2Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... SAN DIEGO, Dec. 12, 2011  Daiichi Sankyo Company, Limited ... pooled analysis showing that edoxaban, a direct oral once-daily ... venous thromboembolism (VTE) following total knee or hip arthroplasty, ... lower incidence of a composite of deep vein thrombosis ...
... Partnership (SRP) Inc. today announced the availability of ... Third Party Administrators (TPAs), brokers, and other users to ... software tools and the need for expensive outsourcing, SRP,s ... affordable licensing rates with no initial subscription fees. ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans 2
(Date:5/3/2015)... Metamora, Michigan (PRWEB) May 03, 2015 ... mark on their Facebook page. , Their ... on the many services the Practice has, it’s multiple ... events. , Women’s Excellence has a very strong social ... Pinterest, Instagram and You Tube. , Women’s Excellence ...
(Date:5/3/2015)... " Bubbly Walrus ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... games to play on smartphones are the ones that get ... with a video game that just absorbs attention, why not ...
(Date:5/3/2015)... May 03, 2015 Looking for ... will directly impact your career? The Master of ... dynamic leaders in multinational companies and for professionals ... a changing global landscape, differences in culture, religion, ... The EMIB program develops the global competence and ...
(Date:5/3/2015)... 2015 It is not too late to register ... in Memory of Lissa Anne Been in Arnold, Missouri on ... family-friendly event to honor her loving memory. It has benefited the ... Just having turned 37, Lissa suffered a brain aneurysm . ... 24, 2012. This event is designed to serve as a remembrance ...
(Date:5/2/2015)... Las Vegas, NV (PRWEB) May 02, 2015 ... vs. Pacquiao tickets for the long awaited event today, ... Las Vegas. Diehard boxing fans will be able to ... circuit events. , The fight that boxing fans have wanted ... a few months ago. Floyd “Money” Mayweather will step inside ...
Breaking Medicine News(10 mins):Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
... WHITE PLAINS, N.Y., Feb. 25 When Jacqueline,Savage ... products,splashed in luscious color, got the devastating news that ... it brought,things into perspective for her. It also created ... Presley, president and CEO,Carolina Pad & Paper (CPP), with ...
... 100% Nectarine Juices for a Healthier You, ORLANDO, Fla., ... and exercise more in 2008 but still find yourself having ... too late to implement your,New Year,s resolutions and Sun Shower(TM) ... have a healthier 2008., "It,s not too late to ...
... expanded more than 30% in 2007, ... according to Millennium Research Group, WALTHAM, Mass., ... small-diameter (less than or equal to 3.0 mm),dental implants are ... growing at a faster rate than those of regular-diameter,(> 3.0 ...
... An experimental anti-HIV gel is safe for women ... at the University of Alabama at Birmingham (UAB) and ... showed the gel, called tenofovir, was favorably self-applied and ... and AIDS prevention efforts focused on next-generation microbicides to ...
... a survey of over 3.6 million patient records held by ... undiagnosed diabetes. This could help identify tens of thousands of ... is published in the March issue of the British Journal ... of the University of Warwick with colleagues from Nottingham University, ...
... LodgeNet Healthcare to Demonstrate its Interactive Patient Television ... ... Feb. 25 LodgeNet,Healthcare, a unit of LodgeNet Interactive Corporation (Nasdaq: ... that hospitals with,interactive patient television systems enjoyed greater patient satisfaction,ratings and ...
Cached Medicine News:Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 2Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 3Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 4Health News:Still Time to Make a 'Healthy Diet' New Year's Resolution 2Health News:Small-Diameter Dental Implants Increasingly Popular In the US 2Health News:Anti-HIV gel proven safe, tolerable for women 2Health News:GP's databases could identify tens of thousands with undiagnosed diabetes in UK 2Health News:Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows 2Health News:Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows 3
... gel drying system, 100-120 V, includes Model 583 ... Model 583 gel dryer is a vacuum-based gel ... 45 cm with variable temperature control and three ... water-based pump used for pulling vacuum on gel ...
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... is the most versatile power supply in ... 1000 volts or 1250 milliamps or 325 ... other 1000 volt power supply is capable ... protein gels or small focusing gels and ...
... DNA sequencing, Thermo Series 90 high voltage ... applications. These power supplies can operate ... power operating modes, with automatic crossover. To ... the Series 90 power supplies, four sets ...
Medicine Products: